What is the latest on fish oil supplementation for cardiovascular disease prevention? Dr Manson reviews a new science advisory from the American Heart Association.
Dr Cyrus Desouza reviews GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors, offering advice on which patients may benefit from each class.